Physician profile
Leslie Williams
NPI 1992053854
$6,629.05
in general payments reported to CMS, 2019-2025
45 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,316 · 2022: $1,199 · 2023: $1,100 · 2024: $1,652 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,956 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,956.39 |
| Education | $158.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,005.96 | 2021-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $916.09 | 2021-2025 | Airsupra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $831.18 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $456.15 | 2021-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $437.99 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $329.80 | 2021-2025 | Glassia, Hyqvia |
| Genzyme Corporation | $232.30 | 2022-2025 | |
| Mylan Specialty L.P. | $205.28 | 2021-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $192.55 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Baxter Healthcare | $176.93 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Hospital Products INC. | $174.02 | 2021-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $173.78 | 2022-2024 | Opsumit, Uptravi |
| Insmed, INC. | $152.94 | 2021-2025 | Arikayce, Brinsupri |
| Shionogi INC | $94.50 | 2021-2024 | Fetroja |
| Verona Pharma, INC. | $94.23 | 2025 | Ohtuvayre |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.